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abstract
Keywords:

Heroin continues to be the main drug used in Malaysia, whereas amphetamine-type

Amphetamine type stimulants

stimulants (ATSs, such as ecstasy, syabu, and yaba) have been recently identified as a

Drug user

growing problem. A cumulative total of 300,241 drug users were detected between 1988 and

Heroin

2006. It is also estimated that Malaysia has 170,000 injecting drug users. Human immu-

Human immunodeficiency virus

nodeficiency virus (HIV) prevalence among drug users in the country ranges from 25% to

Opiates

45%. Currently, there are approximately 380 general medical practice offices that offer
agonist maintenance treatments for approximately 10,000 patients. There are 27,756 active
patients in 333 general medical practice offices and government-run methadone maintenance treatment (MMT) centers. The needle syringe exchange program reached out to
34,244 injection drug users in 2011. In the past 2 years (2011 and 2012) the number of
detected drug addicts decreased from 11,194 to 9015. The arrests made by the police related
to opiate and cannabis use increased from 41,363 to 63,466 between the years 2008 and
2010, but decreased since 2010. An almost four-fold increase in the number of ATS and
ketamine users was detected from 2006 (21,653 users) to 2012 (76,812). Between 2004 and
2010, the yearly seizures for heroin ranged from 156 kg to 270 kg. However, in 2010 and
2011, heroin seizures showed a significant increase of 445 kg and 410.02 kg, respectively.
There has been a seizure of 600e1000 kg of syabu yearly from 2009 to 2012. Similar to
heroin, increased seizures for yaba have also been observed over the past 2 years. A significant increase has also been recorded for the seizures of ecstasy pills from 2011 (47,761
pills) to 2012 (634,573 pills). The cumulative number of reported HIV infections since 1986 is
94,841. In 2011, sexual activity superseded injection drug use as the main transmission
factor for the epidemic. HIV in the country mainly involves males, as they constitute 90% of
cumulative HIV cases and a majority of those individuals are IDUs. However, HIV infection
trends are shifting from males to females. There are 37,306 people living with HIV who are
eligible for treatment, and 14,002 people living with HIV were receiving antiretroviral
treatment in 2011. The decreasing trend of heroin users who have been detected and
arrested could be due to the introduction of medical treatments and harm reduction approaches for drug users, resulting in fewer drug users being arrested. However, we are
unable to say with certainty why there has been an increase in heroin seizures in the
country. There has been an increasing trend in both ATS users and seizures. A new trend of
concurrent opiate dependence and ATS underscores the need to develop and implement
effective treatments for ATS, concurrent opiate and ATS, and polysubstance abuse disorders. The low numbers of needle syringe exchange program clients being tested for HIV
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underscores our caution in interpreting the decline of HIV infections among drug users and
the importance of focusing on providing education, prevention, treatment, and outreach to
those who are not in treatment.
Copyright ª 2013, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan
LLC. All rights reserved.

1.

Introduction

Malaysia is an Islamic country in Southeast Asia with a population of 29,703,240 [1]. It is situated close to the golden triangle and, historically, opium was used in Malaysia largely by
the Chinese immigrants. In 1929, it had 52,313 registered
opium users. By 1941, there were 75,000 opium users. The
hippy culture in the 1970s and the Vietnam War resulted in
the introduction of cannabis and heroin to Malaysia [2]. Heroin is commonly smoked or injected in Malaysia. Recently,
amphetamine-type stimulants (ATSs), including crystal
methamphetamine and various other methamphetamine
and/or amphetamine-containing substances/pills, have been
identified as a growing problem, not only in Malaysia but also
throughout the Southeast Asia Region [3e5]. In our previous
study, approximately 60% of opioid injecting drug users (IDUs)
in Malaysia reported lifetime use of ATS, with 29% also
reporting lifetime injection of ATS [6].
Between 1988 and 2006, a cumulative total of 300,241 drug
users were detected, representing about 1.1% of the total
population [7]. It is estimated that there are 170,000 IDUs in
the country [8]. Human immunodeficiency virus (HIV) prevalence among drug users in Malaysia ranges from 25% to 45%
[9]. In another previous study of ours, HIV prevalence of 43.9%
was reported among IDUs not in treatment [6].
Malaysia’s drug policy was largely shaped from a security
standpoint, with the Ministry of Home Affairs being responsible for dealing with issues related to drug use and drug
trafficking. Subsequently, this meant that the problem of drug
use was largely seen as a threat to national security. Severe
criminal penalties were given to drug users, which often
included prison sentences. In regard to drug treatment, only
mandatory institutional drug rehabilitation for a period of 2
years was provided through the criminal justice system.
These mandatory institutional facilities did not provide
medically assisted treatment programs and were more geared
towards rehabilitating the physical aspects of the drug user.
This program was not successful and resulted in high relapse
rates, ranging from 70% to 90% within the first year following
discharge [10].
In response to the continuing problems with heroin
dependence and the emerging HIV/AIDS epidemic resulting
from injecting drug use, Malaysia introduced opiate agonist
maintenance treatment. Buprenorphine and methadone
were approved in 2002 and 2003, respectively. Besides
introducing opiate agonist maintenance treatment,
Malaysia also implemented a needle syringe exchange program (NSEP) and started restructuring its mandatory institutional rehabilitation program. Currently, approximately
380 general medical practice offices offer agonist maintenance treatments for approximately 10,000 patients. There

are 27,756 active patients in 333 general medical practice
offices and government-run methadone maintenance
treatment (MMT) centers. MMT programs were also introduced into prisons in 2008, which had expanded to 18 MMTs
in prisons by 2011. Twenty-one government-run compulsory drug rehabilitation centers are still open (including one
center for females), with a total of 5102 residents/inmates
undergoing rehabilitation in 2012. Forty-two voluntary government treatment and rehabilitation centers, known as
Cure and Care Service Centres, had 1836 residential and
176,929 nonresidential inmates/patients in 2012. The NSEP
started in 2006 and has reached out to 34,244 IDUs, with an
average distribution of needle/syringe sets of about 116/IDU/
year (2011).
In this paper, we will describe and discuss the trends of
substance abuse and HIV in Malaysia.

2.

Methods

Secondary data were collected by the authors mainly from the
National Anti Drug Agency, which manages the national
database on drug abuse in Malaysia, the Royal Malaysian Police, which maintains all drug seizure data, and the Ministry of
Health, which maintains the HIV/AIDS database in the country. In addition to local databases, country data from the
United Nations Office on Drugs and Crime and United Nations
country reports were used. A literature search using the
Internet was conducted to identify other relevant published
studies.

3.

Results

3.1.

Drug use

Similar trends in the number of drug addicts detected and
number of drug users arrested are observed in Figs. 1 and 2;
there was an increase between 2008 and 2010 and a decrease
from 2010 to 2012.
In Fig. 2, the Section 3(1) Drug Dependents Act (Treatment
and Rehabilitation) 1983 refers to drug users who were
arrested by the police. They tested positive for opiates or
cannabis but had not been determined to be addicted to
drugs; whereas in Fig. 1, the data provided by the National
Anti Drug Agency are for those who have been medically
certified to be addicted to drugs. We could not obtain data
from 2000 to 2005 for arrests made under Section 3(1) Drug
Dependents Act to compare with the number of detected drug
users detected shown in Fig. 1.
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Years and exact values
Fig. 1 e Number of drug addicts detected from 2000 to 2012. Source: National Anti Drug Agency (2013).

Approximately 30,000e40,000 drug addicts were detected
annually from 2000 to 2005. The number of drug addicts
detected between 2004 and 2008 decreased considerably (from
38,672 to 12,352) and increased (from 15,736 to 23,642) in 2009
and 2010. In the past 2 years (2011 and 2012), the number of
drug addicts detected by the National Anti Drug Agency
decreased from 11,194 to 9015 (Fig. 1).
In terms of arrests made by the police under Section 3(1) Drug
Dependents Act (Fig. 2) related to opiate and cannabis use, there
was an increase from 41,363 arrests to 63,466 arrests between
2008 and 2010, whereas a decrease has been observed since 2010.
The decrease in the number of detected drug addicts can be
attributed to the introduction of needle exchange programs
and also the availability of medical treatments by private

general practitioners (GPs). Prior to the implementation of
these programs, GPs were not allowed to treat drug addicts but
were required to report drug addicts to the government, which
mandated them to undergo compulsory institutional rehabilitation. Currently, private GPs who treat drug addicts are
not required to inform the government; hence, we think that
this is the reason for the lower number of drug addicts being
detected in the country.
Fig. 3 shows arrests made under Section 15(1) Dangerous
Drug Act of 1952. This act applies when an individual tests
positive for using dangerous drugs and does not need to be
medically certified as being drug dependent. In Malaysia,
mostly ATS and ketamine users are charged under this section. There was almost a four-fold increase in the number of

Fig. 2 e Arrests under Section 3(1) Drug Dependents Act (Treatment and Rehabilitation) 1983, related to opiate and cannabis
drug use from 2006 to 2012. Source: Royal Malaysia Police (2012).
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Fig. 3 e Arrests under Section 15(1)(a) Dangerous Drug Act 1952 (DDA) related to party drug use from 2006 to 2012. Source:
Royal Malaysia Police (2013).

ATS and ketamine users detected from 21,653 in 2006 to 76,812
in 2012. This increase, which was documented by the national
database, is also supported by surveys conducted by the authors as shown in Fig. 4’s timelines of initiation of illicit use of
heroin and ATS in a sample of 732 not-in-treatment active
opiate injectors in Kuala Lumpur, Johor Bahru, and Penang,

Malaysia [11]. Fig. 4 illustrates that the cumulative proportion
of individuals initiating heroin use increased steadily beginning in the late 1960s. ATS use was negligible until 1987 (only
one person reported initiation of ATS prior to 1987). The
number of participants initiating ATS use increased slowly
over the next number of years, prior to rising rapidly after

Fig. 4 e Onset of ATS abuse in Malaysia (Chawarski et al [11]).
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Table 2 e Overview of the human immunodeficiency
virus (HIV) epidemic in Malaysia 2011.
Indicator

ATS = amphetamine-type stimulants; HIV = human immunodeficiency virus

Fig. 5 e Lifetime ATS use and HIV infection rates.

1997. By 2008, 75% of the participants had initiated ATS use. In
this sample, we also observed a strong association between
lifetime ATS use and HIV infection rates (Fig. 5).

3.2.

Drug seizures

Over the past 2 years, a significant increase in heroin seizures
has been observed. Between 2004 and 2010, the yearly seizure
of heroin was 156e270 kg. However, in 2010 and 2011, heroin
seizures showed an increase of 445 kg and 410.02 kg, respectively. This is in contrast to the number of drug users detected
and arrested for the same period (2010 and 2011), when a
decreasing trend was observed.
With regard to ATSs (yaba, syabu, and ecstasy), there has
been a seizure of 600e1000 kg of syabu yearly from 2009 to
2012. Similar to heroin, increased seizures for yaba have also
been observed over the past 2 years. A significant increase has
also been recorded for the seizures of ecstasy pillsdfrom
47,761 pills in 2011 to 634,573 pills in 2012.
Ketamine seizures have dropped from 378 kg seized in 2010
to 106 kg in 2011 and 118.07 in 2012. Similarly, cannabis seizures
also recorded a downward trend from 2010. Table 1 shows the
trend of seizures of drugs in Malaysia from 2004 to 2012.

3.3.

HIV/AIDS situation

The cumulative total of reported HIV infections since 1986 is
94,841. Table 2 provides an overview of the HIV epidemic in
Malaysia. In the 1990s, about 70e80% of HIV infections in the

No./%

Cumulative total of reported HIV infections
since first detection in 1986
Cumulative total of reported AIDS since 1986
Cumulative total of reported deaths related
to HIV/AIDS since 1986
Estimated no. of people living with HIV
New HIV infections detected in 2011
Notification rate of HIV (per 100,000) in 2011
Women reported with HIV in 2011
Cumulative no. of women reported with
HIV as of December 2011
Children aged below 13 with HIV in 2011
Cumulative total of children under 13
with HIV as of December 2011
Estimated no. of people living with HIV
eligible for treatment
No. PLHIV receiving ART (surveillance
data) as of December 2011

94,841
17,686
14,986
81,000
3479
12.18
735
9494
65
974
37,306
14,002

Source: Ministry of Health Malaysia (2012).

country were attributed to IDUs. However, in 2011, HIV infection rates among IDUs declined to 38.7%. This is due to the
implementation of harm reduction programs in 2005. These
rates are projected to drop to 10% in 2015 [12]. In 2011, sexual
transmission superseded injecting drug use as the main factor
for the epidemic, with a ratio of six sexual transmissions for
every four IDU transmissions reported. HIV in the country also
mainly affects males, who make up 90% of cumulative HIV
cases, and the majority of these individuals are IDUs. However,
a growing number of females are being infected with HIV. The
trend of the male-to-female ratio of HIV infection shifted from
1:99 in 1990 to 1:10 in 2000 and 1:4 in 2011 [12].
There are 37,306 people living with HIV who are eligible for
treatment, and 14,002 of these (37.4%) were receiving antiretroviral treatment (ART) in 2011. Malaysia provides first-line
ART for free, and ART is also made available for incarcerated
populations. The second-line protease inhibitor-based regime
is also subsidized by the government [12].
The annual reported number of new HIV infections
declined from 6978 cases in 2002 to 3479 in 2011. The notification rate of HIV (new and recurrent episodes notified to
Malaysian Ministry of Health for a given year, expressed/
100,000 population) also decreased from 28.4 in 2002 to 23.4 in
2005, and to 12.2 cases/100,000 population in 2011 [8].
Providing free first-line and affordable second-line ART has

Table 1 e Seizures of drugs in Malaysia from 2004 to 2012.

Heroin (kg)
Cannabis (kg)
Syabu (kg)
Ketamine (kg)
Yaba (pills)
Ecstasy (pills)

2004

2005

2006

2007

2008

2009

2010

2011

2012

183
1031
63
11
92,549
103,895

221
920
37
396
108,430
114,887

156
2216
139
190
242,732
252,231

243
705
65
178
121,629
151,211

270
751
355
241
197,343
80,800

217
1734
1093
378
107,573
67,775

234
953
760
268
107,963
60,713

445
796
830
106
36,487
47,761

410.02
751.80
608.67
118.07
521,384
634,573

Source: Royal Malaysia Police (2013).
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also resulted in a decline of AIDS-related deaths. In 2011, 14,00
> PLHIV were in treatment, which is 77.5% of the estimated
PLHIV eligible for ART treatment.
We would like to caution that although declining rates are
encouraging, the introduction of harm reduction programs has
also resulted in fewer drug users being tested for HIV. Prior to
the implementation of harm reduction programs, all detected
drug users who were mandated to undergo mandatory institutional rehabilitation were tested upon entry to these centers.

4.

Discussion

The numbers of heroin addicts detected (Fig. 1) and opiate
users arrested (Fig. 2) decreased in 2011 and 2012, whereas the
seizures of heroin in the country for the same period almost
doubled. We think that the decreasing trend observed in Figs.
1 and 2 is due to the introduction of medical treatments and
harm reduction approaches for drug users.
We are, however, unable to say for certain why there has
been an increase in heroin seizures in the country. A plausible
reason is an obvious increase in demand for heroin in the
country. As explained above, the lower number of drug users
detected may not necessarily reflect a decreasing trend of
drug users in the country. The data provided for heroin seizures in the country are for heroin No. 3, which is for local
consumption. Only heroin No. 4 is exported, so the argument
that this seized heroin is heading for the international drug
market is not plausible. The second potential reason is that
Malaysia is often regarded as a transit country for the trafficking of drugs to Australia.
The number of drug users arrested for ATS and ketamine
has increased significantly since 2006. Seizures for ATS have
also increased, whereas ketamine seizures have decreased
over the past 2 years. ATS abuse and opioid dependence are
highly prevalent, frequently coincide, and are the major
drivers of the HIV and other major public health problems in
Malaysia and throughout Asia. ATS abuse by MMT patients
may also undermine the effectiveness of MMT.
These new trends, particularly in concurrence with opiate
dependence, underscore the need to develop and implement
effective treatments for ATS, concurrent opiate and ATS use,
and polysubstance abuse disorders. The importance of using a
medical model for treatment of drug users needs to be
emphasized. This should include using medications and psychosocial interventions. Once individuals enter into drug
treatment programs, there also is a higher likelihood that those
who are HIV-positive will be able to enroll in HIV treatment.
Although we have shown from our survey data that lifetime
ATS use is linked to increased HIV infection rates, more studies
and more behavioral data are needed to understand the link
between ATS use and HIV infection in local settings. Colfax et al
[13] and Degenhardt [14], have shown that ATS use might
contribute to HIV infection through a number of behavioral and
biological pathwaysdincreased energy and sexual activity,
impaired judgment leading to unsafe sexual practices,
increased injecting drug use and sharing of equipment, and
more impulse-sharing in high risk situations.
The introduction of NSEP is commendable, considering the
barriers that the government and nongovernmental
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organizations had to overcome in 2006 to implement the
nationwide program [15]. However, after several years of
implementation, the proportions of clients being referred to
voluntary counseling and testing and MMT are low, with only
approximately 10% of NSEP clients referred to voluntary
counseling and testing and 4% referred to and entering MMT
[8]. The low numbers of NSEP clients being tested for HIV
underscores our caution in interpreting the decline of HIV
infections among drug users and the importance of focusing
on providing education, prevention, treatment, and outreach
to populations of not-in-treatment current drug users.
As Malaysia has, only over the past several years, allowed
private medical practitioners to treat drug users in the country, there is a need to provide training to more physicians,
especially training on how to dispense medication in a proper
way for GPs. Similarly, there is a need to provide counselors
with high quality counseling training.
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